Lorem ipsum dolor sit amet consectetur adipiscing elit, facilisis nulla aptent sodales senectus mollis. Elementum montes quisque nostra massa eget viverra tempor lectus fusce malesuada blandit, quam morbi nec rutrum convallis euismod metus primis ac mattis, odio arcu cursus mauris lacus eros mollis at parturient scelerisque.
Medi Linx Laboratory celebrated its 6th anniversary last September 22 with the theme “Unstoppable Growth.Unparalleled Care to Patients and Partners.”
The event was led by Medi Linx President and CEO, Ms. Maria Estella P. Diokno and was graced by Metro Pacific Health’s Vice Chairman and President, Mr. Augusto P. Palisoc Jr. and Group Chief Executive Officer, Dr. Harish Pillai.
Immunochemistry is a critical diagnostic tool that helps in achieving a more precise diagnosis of a disease, which - in turn - will translate into better care and management of patients. In Medi Linx, the Immunochemistry section offers more than 200 assays, with wide...
In a Key Turnover and Contract Signing Ceremony held on February 2, 2024, Medi Linx Laboratory (Medi Linx) has officially signed a partnership agreement with Davao Doctors Hospital (DDH) to foster a culture of excellence and innovation that will further enhance the...
Medi Linx Laboratory Inc. (MLLI) has successfully expanded its footprint to Mindanao after officially signing a laboratory management contract with St. Elizabeth Hospital, Inc. (SEHI), a premier health institution located in General Santos City, South Cotabato....
At MEDI LINX LABORATORY INC., we are committed to safeguarding the privacy and security of your personal and health-related information. This data privacy statement outlines how we collect, use, disclose, and protect your data to ensure compliance with applicable laws and regulations, including but not limited to Republic Act No. 10173, its Implementing Rules and Regulations, and the issuance/s set forth by the National Privacy Commission (NPC).
Click here to read the Data Privacy Statement in full.